Journal of Hepatology
Volume 48, Issue 5 , Pages 835-847 , May 2008

Non-invasive evaluation of liver fibrosis using transient elastography

  • Laurent Castera

      Affiliations

    • Departments of Hepatology, Hospital Saint-André & Haut Lévêque, University Hospital of Bordeaux, Bordeaux, France
    • Corresponding Author InformationCorresponding author. Address: Service d’Hépato-Gastroentérologie, C.H.U. Bordeaux, Hôpital Haut Lévêque, Avenue Magellan, 33604 Pessac, France. Tel.: +33 5 57 65 64 39; fax: +33 5 57 65 64 45.
    • ,
  • Xavier Forns

      Affiliations

    • Liver Unit, Hospital Clinic, IDIBAPS, Ciberehd, Barcelona, Spain
    • ,
  • Alfredo Alberti

      Affiliations

    • Department of Clinical and Experimental Medicine and Venetian Institute of Molecular Medicine (VIMM), University of Padova, Padova, Italy

References 

  1. EASL International Consensus Conference on hepatitis C. Paris, 26–27 February 1999. Consensus statement. J Hepatol 1999;31(Suppl. 1):3–8.
  2. NIH Consensus Statement on Management of Hepatitis C: 2002. Hepatology 2002;36:S3–S20.
  3. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001;344:495–500
  4. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the group of epidemiology of the french association for the study of the liver (AFEF). Hepatology. 2000;32:477–481
  5. Castera L, Negre I, Samii K, Buffet C. Pain experienced during percutaneous liver biopsy. Hepatology. 1999;30:1529–1530
  6. Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003;38:1449–1457
  7. Rousselet MC, Michalak S, Dupre F, Croue A, Bedossa P, Saint-Andre JP, et al. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology. 2005;41:257–264
  8. Afdhal NH. Diagnosing fibrosis in hepatitis C: is the pendulum swinging from biopsy to blood tests?. Hepatology. 2003;37:972–974
  9. Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol. 2004;99:1160–1174
  10. Rockey DC, Bissell DM. Non-invasive measures of liver fibrosis. Hepatology. 2006;43:S113–S120
  11. Castera L, Pawlotsky JM. Non-invasive diagnosis of liver fibrosis in patients with chronic hepatitis C. MedGenMed. 2005;7:39
  12. Sebastiani G, Alberti A. Non-invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. World J Gastroenterol. 2006;12:3682–3694
  13. Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new non-invasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29:1705–1713
  14. Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi G, et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut. 2007;56:968–973
  15. Kettaneh A, Marcellin P, Douvin C, Poupon R, Ziol M, Beaugrand M, et al. Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. J Hepatol. 2007;46:628–634
  16. Lucidarme D, Foucher J, Le Bail B, Castera L, Villars S, Forzy G, et al. The ratio interquartile range/median value of liver stiffness measurements is a key factor of accuracy of transient elastography (FibroScan) for the diagnosis of liver fibrosis (abstract). Hepatology. 2007;46:318A
  17. Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128:343–350
  18. Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, et al. Non-invasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology. 2005;41:48–54
  19. Foucher J, Chanteloup E, Vergniol J, Castera L, Le Bail B, Adhoute X, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut. 2006;55:403–408
  20. Ganne-Carrie N, Ziol M, de Ledinghen V, Douvin C, Marcellin P, Castera L, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology. 2006;44:1511–1517
  21. Coco B, Oliveri F, Maina AM, Ciccorossi P, Sacco R, Colombatto P, et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat. 2007;14:360–369
  22. Foucher J, Castera L, Bernard PH, Adhoute X, Laharie D, Bertet J, et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol. 2006;18:411–412
  23. Arena U, Vizzutti F, Corti G, Ambu S, Stasi C, Bresci S, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology. 2008;47:380–384
  24. Sagir A, Erhardt A, Schmitt M, Haussinger D. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology. 2007;47:592–595
  25. Konate A, Reaud S, Quenemer E, Fouchard-Hubert I, Oberti F, Cales P. Liver stiffness measurement by transient elastography: predictive factors of accuracy and reproducibility (abstract). J Hepatol. 2006;44:S195
  26. Roulot D, Czernichow S, Le Clésiau H, Costes J-L, Vergnaud A-C, Beaugrand M. Liver stiffness values in apparently healthy subjects: Influence of gender and metabolic syndrome. J Hepatol. 2008;48:606–613
  27. Corpechot C, El Naggar A, Poupon R. Gender and liver: is the liver stiffness weaker in weaker sex?. Hepatology. 2006;44:513–514
  28. Kim KM, Choi WB, Park SH, Yu E, Lee SG, Lim YS, et al. Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy individuals: a prospective study of living related potential liver donors. J Gastroenterol. 2007;42:382–388
  29. Afdhal NH, Curry M. Technology evaluation: a critical step in the clinical utilization of novel diagnostic tests for liver fibrosis. J Hepatol. 2007;46:543–545
  30. Gomez-Dominguez E, Mendoza J, Rubio S, Moreno-Monteagudo JA, Garcia-Buey L, Moreno-Otero R. Transient elastography: a valid alternative to biopsy in patients with chronic liver disease. Aliment Pharmacol Ther. 2006;24:513–518
  31. Marcellin P, de Ledinghen V, Dhumeaux D, Poupon R, Ziol M, Bedossa P, et al. Non-invasive assessment of liver fibrosis in chronic hepatitis B using FibroScan (abstract). Hepatology. 2005;42:715A
  32. de Ledinghen V, Douvin C, Kettaneh A, Ziol M, Roulot D, Marcellin P, et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr. 2006;41:175–179
  33. Vergara S, Macias J, Rivero A, Gutierrez-Valencia A, Gonzalez-Serrano M, Merino D, et al. The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection. Clin Infect Dis. 2007;45:969–974
  34. Corpechot C, El Naggar A, Poujol-Robert A, Ziol M, Wendum D, Chazouilleres O, et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology. 2006;43:1118–1124
  35. Kelleher T, MacFarlane C, de Ledinghen V, Beaugrand M, Foucher J, Castera L, et al. Risk factors and hepatic elastography (FibroScan) in the prediction of hepatic fibrosis in non-alcoholic steatohepatitis (abstract). Gastroenterology. 2006;130:A736
  36. Yoneda M, Fujita K, Inamori M, Nakajima A, Tamano M, Hiraishi H. Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD). Gut. 2007;56:1330–1331
  37. Talwalkar JA, Kurtz DM, Schoenleber SJ, West CP, Montori VM. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2007;5:1214–1220
  38. Castera L, Bernard PH, Le Bail B, Foucher J, Merrouche W, Couzigou P, et al. What is the best non-invasive method for early prediction of cirrhosis in chronic hepatitis C? Prospective comparison between Fibroscan and serum markers (Lok index, APRI, AST/ALT ratio, platelet count and Fibrotest) (abstract). Hepatology. 2007;46:156A
  39. Poynard T, Halfon P, Castera L, Munteanu M, Imbert-Bismut F, Ratziu V, et al. Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin Chem. 2007;53:1615–1622
  40. Poynard T, Ingiliz P, Munteanu M, Lebray P, Morra R, Messous D, et al. Concordance between FibroTest (FT) and FibroScan (FS): a new non-invasive methodology to improving accuracy in a world without a gold standard (abstract). Hepatology. 2007;44:189A
  41. Castera L, Le Bail B, Foucher J, Bertet J, Darriet M, Couzigou P, et al. Prospective analysis of discordance between FibroScan and FibroTest when used in combination as first-line assessment of liver fibrosis in chronic hepatitis C (Abstract). Hepatology. 2005;42:440A
  42. Non-invasive methods for the evaluation of hepatic fibrosis/cirrhosis. www.has-sante.fr, 2006.
  43. Martinez SM, Domı´nguez M, Fernandez-Varo G, Gonzalez P, Bataller R, Sampson E, et al. Performance of non-invasive methods in the assessment of disease severity in routine clinical practice in patients with chronic hepatitis C (abstract). Hepatology. 2007;46:318A
  44. Sebastiani G, Vario A, Guido M, Noventa F, Plebani M, Pistis R, et al. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol. 2006;4:686–693
  45. Castera L, Sebastiani G, Le Bail B, de Ledinghen V, Couzigou P, Alberti A. Prospective comparison of two algorithms combining non-invasive tests for staging of fibrosis in chronic hepatitis C (abstract). Hepatology. 2007;46:320A
  46. Castera L, Foucher J, Bertet J, Couzigou P, de Ledinghen V. FibroScan and FibroTest to assess liver fibrosis in HCV with normal aminotransferases. Hepatology. 2006;43:373–374
  47. Colletta C, Smirne C, Fabris C, Toniutto P, Rapetti R, Minisini R, et al. Value of two non-invasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology. 2005;42:838–845
  48. Moreno-Otero R, Trapero-Marugan M, Mendoza J. Liver fibrosis assessment by transient elastography in hepatitis C patients with normal alanine aminotransferase. Gut. 2006;55:1055–1056
  49. Castera L, Foucher J, Bernard PH, Bertet J, Couzigou P, de Lédinghen V. Transient elastography (FibroScan) and FibroTest to assess liver fibrosis in inactive hepatitis B carriers: a prospective controlled study (abstract). Hepatology. 2006;44:489A
  50. Pinzani M. Non-invasive evaluation of hepatic fibrosis: don’t count your chickens before they’re hatched. Gut. 2006;55:310–312
  51. Kazemi F, Kettaneh A, N’Kontchou G, Pinto E, Ganne-Carrie N, Trinchet JC, et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol. 2006;45:230–235
  52. Vizzutti F, Arena U, Romanelli RG, Rega L, Foschi M, Colagrande S, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology. 2007;45:1290–1297
  53. Carrion JA, Navasa M, Bosch J, Bruguera M, Gilabert R, Forns X. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl. 2006;12:1791–1798
  54. Bureau C, Metivier S, Peron JM, Robic MA, Rouquet O, Dupuis E, et al. Prospective assessment of liver stiffness for the non-invasive prediction of portal hypertension (abstract). J Hepatol. 2007;46:S34
  55. Lemoine M, Katsahian S, Nahon P, Ganne-Carrie N, Kazemi F, Grando V, et al. Liver stiffness measurement is correlated with hepatic venous pressure gradient in patients with uncomplicated alcoholic and/or HCV related cirrhosis (abstract). Hepatology. 2006;44:204A
  56. Garcia-Samaniego J, Forns X. Hepatitis C virus and human immunodeficiency virus: the un-won battle. Hepatology. 2007;46:611–614
  57. Lim JK, Groszmann RJ. Transient elastography for diagnosis of portal hypertension in liver cirrhosis: is there still a role for hepatic venous pressure gradient measurement?. Hepatology. 2007;45:1087–1090
  58. Bosch J. Predictions from a hard liver. J Hepatol. 2006;45:174–177
  59. Bureau C, Robic MA, Metivier S, Peron JM, Rouquet O, Dupuis E, et al. Prognostic value of liver stiffness measurement and hepatic venous pressure gradient in patients with chronic liver disease: a prospective study (abstract). Hepatology. 2007;46:572A
  60. Rigamonti C, Donato MF, Fraquelli M, Agnelli F, Ronchi G, Casazza G, et al. Transient elastography predicts fibrosis progression in patients with recurrent hepatitis c after liver transplantation. Gut. 2008;
  61. Castera L, Denis J, Babany G, Roudot-Thoraval F. Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: Time for new guidelines?. J Hepatol. 2007;46:528–529
  62. deLedinghen V, Castera L, Foucher J, Tournan R, Bernard PH, Moisset G, et al. Evaluation of fibrosis evolution using non-invasive methods according to sustained virological response in HCV patients: a pilot prospective controlled study (abstract). Hepatology. 2006;44:337A
  63. Hézode C, Castéra L, Rosa I, Roulot D, Leroy V, Bouvier-Alias M, et al. Dynamics of liver stiffness during peginterferon alpha-ribavirin treatment in patients with chronic hepatitis C (abstract). Hepatology. 2007;46:366A
  64. Takeda T, Yasuda T, Nakayama Y, Nakaya M, Kimura M, Yamashita M, et al. Usefulness of non-invasive transient elastography for assessment of liver fibrosis stage in chronic hepatitis C. World J Gastroenterol. 2006;12:7768–7773
  65. de Ledinghen V, Le Bail B, Rebouissoux L, Fournier C, Foucher J, Miette V, et al. Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy. J Pediatr Gastroenterol Nutr. 2007;45:443–450
  66. Huwart L, Sempoux C, Salameh N, Jamart J, Annet L, Sinkus R, et al. Liver fibrosis: non-invasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology. 2007;245:458–466
  67. Yin M, Talwalkar JA, Glaser KJ, Manduca A, Grimm RC, Rossman PJ, et al. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol. 2007;5:1207–1213
  68. Friedrich-Rust M, Ong MF, Herrmann E, Dries V, Samaras P, Zeuzem S, et al. Real-time elastography for non-invasive assessment of liver fibrosis in chronic viral hepatitis. AJR Am J Roentgenol. 2007;188:758–764
  69. Lewin M, Poujol-Robert A, Boelle PY, Wendum D, Lasnier E, Viallon M, et al. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology. 2007;46:658–665
  70. Huwart L, Sempoux C, Salameh N, Annet L, Horsmans Y, Van Beers BE. Comparison of MR elastography, ultrasound elastography and APRI for the non-invasive assessment of liver fibrosis (abstract). Hepatology. 2007;46:319A

☆ The authors declare that they do not have anything to disclose regarding funding from industries or conflict of interest with respect to this manuscript.

PII: S0168-8278(08)00123-2

doi: 10.1016/j.jhep.2008.02.008

Journal of Hepatology
Volume 48, Issue 5 , Pages 835-847 , May 2008

Article Tools

* Image Usage & Resolution